Literature DB >> 25648976

Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms.

N M Valenzuela1, K R Trinh2, A Mulder3, S L Morrison2, E F Reed1.   

Abstract

It is currently unclear which donor specific HLA antibodies confer the highest risk of antibody-mediated rejection (AMR) and allograft loss. In this study, we hypothesized that two distinct features (HLA IgG subclass and Fcγ receptor [FcγR] polymorphisms) which vary from patient to patient, influence the process of monocyte trafficking to and macrophage accumulation in the allograft during AMR in an interrelated fashion. Here, we investigated the contribution of human IgG subclass and FcγR polymorphisms in monocyte recruitment in vitro by primary human aortic endothelium activated with chimeric anti-HLA I human IgG1 and IgG2. Both subclasses triggered monocyte adhesion to endothelial cells, via a two-step process. First, HLA I crosslinking by antibodies stimulated upregulation of P-selectin on endothelium irrespective of IgG subclass. P-selectin-induced monocyte adhesion was enhanced by secondary interactions of IgG with FcγRs, which was highly dependent upon subclass. IgG1 was more potent than IgG2 through differential engagement of FcγRs. Monocytes homozygous for FcγRIIa-H131 adhered more readily to HLA antibody-activated endothelium compared with FcγRIIa-R131 homozygous. Finally, direct modification of HLA I antibodies with immunomodulatory enzymes EndoS and IdeS dampened recruitment by eliminating antibody-FcγR binding, an approach that may have clinical utility in reducing AMR and other forms of antibody-induced inflammation. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Alloantibody; basic (laboratory) research/science; cellular biology; heart transplantation/cardiology; immunobiology; macrophage/monocyte biology:trafficking; rejection:antibody-mediated (ABMR); vascular biology

Mesh:

Substances:

Year:  2015        PMID: 25648976      PMCID: PMC4439339          DOI: 10.1111/ajt.13174

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  117 in total

1.  Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection.

Authors:  Alex B Magil; Kathryn Tinckam
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

Review 2.  Adhesion molecule expression on cytokine-stimulated human endothelial cells.

Authors:  Susan L Cuvelier; Kamala D Patel
Journal:  Methods Mol Biol       Date:  2003

3.  The epitope recognized by pan-HLA class I-reactive monoclonal antibody W6/32 and its relationship to unusual stability of the HLA-B27/beta2-microglobulin complex.

Authors:  T M Tran; P Ivanyi; I Hilgert; T Brdicka; M Pla; B Breur; M Flieger; E Ivasková; V Horejsí
Journal:  Immunogenetics       Date:  2001-08       Impact factor: 2.846

Review 4.  Interaction sites on human IgG-Fc for FcgammaR: current models.

Authors:  Roy Jefferis; John Lund
Journal:  Immunol Lett       Date:  2002-06-03       Impact factor: 3.685

5.  Membrane attack complex contributes to destruction of vascular integrity in acute lung allograft rejection.

Authors:  Shinji Nakashima; Zhiping Qian; Salma Rahimi; Barbara A Wasowska; William M Baldwin
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

6.  Flow cytometric determination of FcgammaRIIa (CD32) polymorphism.

Authors:  Annet van Royen-Kerkhof; Elisabeth A M Sanders; Siska Wijngaarden; Joel A G van Roon; Marleen Voorhorst-Ogink; Vanessa Walraven; Arnout Gerritsen; Marc A van Dijk; W Kuis; Ger T Rijkers; Tibor Keler; Jeanette H W Leusen; Jan G J van de Winkel
Journal:  J Immunol Methods       Date:  2004-10-06       Impact factor: 2.303

7.  IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G.

Authors:  Ulrich von Pawel-Rammingen; Björn P Johansson; Lars Björck
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

8.  Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation.

Authors:  C Lefaucheur; C Suberbielle-Boissel; G S Hill; D Nochy; J Andrade; C Antoine; C Gautreau; D Charron; D Glotz
Journal:  Am J Transplant       Date:  2007-12-19       Impact factor: 8.086

9.  Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts.

Authors:  Peter T Jindra; Aileen Hsueh; Longshen Hong; David Gjertson; Xiu-Da Shen; Feng Gao; Julie Dang; Paul S Mischel; William M Baldwin; Michael C Fishbein; Jerzy W Kupiec-Weglinski; Elaine F Reed
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

10.  HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway.

Authors:  Peter T Jindra; Yi-Ping Jin; Enquire Rozengurt; Elaine F Reed
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

View more
  22 in total

1.  Antibody-induced vascular inflammation skews infiltrating macrophages to a novel remodeling phenotype in a model of transplant rejection.

Authors:  Xuedong Wei; Nicole M Valenzuela; Maura Rossetti; Rebecca A Sosa; Jessica Nevarez-Mejia; Gregory A Fishbein; Arend Mulder; Jayeeta Dhar; Karen S Keslar; William M Baldwin; Robert L Fairchild; Jianquan Hou; Elaine F Reed
Journal:  Am J Transplant       Date:  2020-05-22       Impact factor: 8.086

2.  Antibodies to HLA Molecules Mimic Agonistic Stimulation to Trigger Vascular Cell Changes and Induce Allograft Injury.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Curr Transplant Rep       Date:  2015-05-24

3.  The suppressive effect on CD4 T cell alloresponse against endothelial HLA-DR via PD-L1 induced by anti-A/B ligation.

Authors:  K Iwasaki; H Hamana; H Kishi; T Yamamoto; T Hiramitsu; M Okad; T Tomosugi; A Takeda; S Narumi; Y Watarai; Y Miwa; M Okumura; Y Matsuoka; K Horimi; A Muraguchi; T Kobayash
Journal:  Clin Exp Immunol       Date:  2020-07-18       Impact factor: 4.330

4.  Outside-in HLA class I signaling regulates ICAM-1 clustering and endothelial cell-monocyte interactions via mTOR in transplant antibody-mediated rejection.

Authors:  Sahar Salehi; Rebecca A Sosa; Yi-Ping Jin; Shoichi Kageyama; Michael C Fishbein; Enrique Rozengurt; Jerzy W Kupiec-Weglinski; Elaine F Reed
Journal:  Am J Transplant       Date:  2017-11-23       Impact factor: 8.086

Review 5.  Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  J Clin Invest       Date:  2017-06-12       Impact factor: 14.808

Review 6.  The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection.

Authors:  Kimberly A Thomas; Nicole M Valenzuela; Elaine F Reed
Journal:  Trends Mol Med       Date:  2015-03-20       Impact factor: 11.951

7.  Chronic Porphyromonas gingivalis lipopolysaccharide induces adverse myocardial infarction wound healing through activation of CD8+ T cells.

Authors:  Yusra Zaidi; Alexa Corker; Valeriia Y Vasileva; Kimberly Oviedo; Connor Graham; Kyrie Wilson; John Martino; Miguel Troncoso; Philip Broughton; Daria V Ilatovskaya; Merry L Lindsey; Kristine Y DeLeon-Pennell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-10-01       Impact factor: 5.125

8.  Label-free detection of immune complexes with myeloid cells.

Authors:  Z Szittner; A E H Bentlage; P Rovero; P Migliorini; V Lóránd; J Prechl; G Vidarsson
Journal:  Clin Exp Immunol       Date:  2016-05-12       Impact factor: 4.330

Review 9.  Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts.

Authors:  William M Baldwin; Anna Valujskikh; Robert L Fairchild
Journal:  Curr Opin Organ Transplant       Date:  2016-02       Impact factor: 2.640

Review 10.  The divergent roles of macrophages in solid organ transplantation.

Authors:  Sahar Salehi; Elaine F Reed
Journal:  Curr Opin Organ Transplant       Date:  2015-08       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.